A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)

Authors: Joel M. Gelfand, Daniel B. Shin, Abass Alavi, Drew A. Torigian, Tom Werner, Maryte Papadopoulos, Junko Takeshita, Megan H. Noe, Amit K. Dey, Martin P. Playford, Nehal N. Mehta - Journal of Investigative Dermatology 2019 cited by 114